Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of [68Ga]Ga-ABY-025 PET for Non-invasive Quantification of HER2-status in Solid Tumors

NCT05619016 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT05619016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05619016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of [68Ga]Ga-ABY-025 PET for Non-invasive Quantification of HER2-status in Solid Tumors
Lead sponsor
Karolinska University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
November 23, 2022
Completion date
December 31, 2025
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, esophageal neoplasms, gastric neoplasms malignant, her2-positive gastric cancer